Segall Bryant & Hamill, LLC Corcept Therapeutics Inc Transaction History
Segall Bryant & Hamill, LLC
- $6.35 Billion
- Q1 2025
A detailed history of Segall Bryant & Hamill, LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Segall Bryant & Hamill, LLC holds 20,764 shares of CORT stock, worth $1.54 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
20,764
Previous 21,784
4.68%
Holding current value
$1.54 Million
Previous $1.1 Million
116.13%
% of portfolio
0.04%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding CORT
# of Institutions
436Shares Held
84.3MCall Options Held
1.04MPut Options Held
1.33M-
Black Rock Inc. New York, NY16.5MShares$1.22 Billion0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$748 Million0.01% of portfolio
-
Ingalls & Snyder LLC New York, NY8.1MShares$599 Million16.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.2MShares$458 Million0.49% of portfolio
-
Parallel Advisors, LLC3.97MShares$294 Million5.04% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $7.92B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...